心房作为与年龄相关的黄斑退化症的预测因素
Kaden T Bunch1, Heidi T May2, Kirk U Knowlton2
1Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Journal of cardiovascular electrophysiology
|March 11, 2025
概括
患有心房 (AF) 的患者患上与年龄相关的黄斑变性 (AMD) 的风险增加. 这种风险随着时间的推移而增长,这表明管理AF风险因素可能有助于预防AMD.
科学领域:
- 眼科医生 眼科 眼科
- 心脏病学 心脏病学
- 老年学是一门学科.
背景情况:
- 人口老龄化增加了心房动 (AF) 和与年龄相关的黄斑变性 (AMD) 的患病率.
- AF与全身血管问题和炎症有关,可能会影响眼睛等器官.
- 在AF和AMD之间共享的风险因素表明这些条件之间存在潜在的联系.
研究的目的:
- 调查心房动 (AF) 增加患年龄相关黄斑变性 (AMD) 的风险的假设.
主要方法:
- 从INSPIRE研究数据库中对38746名没有先前AMD的患者进行了前性研究.
- 评估AMD发病率在1,5,和长期随访.
- 分析AF和AMD发育之间的关联.
主要成果:
- 在2159天的时间里,30.4%的患者出现了AF. 患有AF的患者年龄较大,并患有更多的并发症.
- 在AF患者中,AMD的发病率显著更高 (2.1%对1.2%).
- AF与长期增长1.8倍的AMD风险有关,尽管通过考虑基线特征和药物可以减轻这种风险.
结论:
- 患有AF的患者面临着患上AMD的风险增加和时间增加.
- 在AF患者中,AMD的风险似乎与驱动AF的潜在风险因素有关.
- 综合管理AF及其风险因素可以减少AMD的发生率.
更多相关视频
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...


